- T22 -

Welcome to ALS Finding a Cure ALS FAC is proud to announce that we provided initial funding for Amylyx which recently received FDA approval for Relyvrio the first new ALS drug in over five years. Projects ALSFAC has invested almost 45 of its budget in Target Identification efforts designed to help better understand the disease. Clinical Trials ALSFAC funding is directed towards new efforts to launch clinicaltherapeutic trials covering a broad range of targets and therapeutic classes. NEWS ALSFAC funded investigators actively disseminate information around ALS clinical and scientific breakthroughs and challenges via print TV social media and through public presentations.